Securities code: 300677 securities abbreviation: Intco Medical Technology Co.Ltd(300677) Announcement No.: 2022-010 Intco Medical Technology Co.Ltd(300677)
Announcement of resolutions of the 47th meeting of the second board of supervisors
The company and all members of the board of supervisors guarantee that the contents of the announcement are true, accurate and complete without false records, misleading statements or major omissions.
1、 Meetings of the board of supervisors
Intco Medical Technology Co.Ltd(300677) (hereinafter referred to as “the company”) the 47th meeting of the second session of the board of supervisors was held by means of communication in the company’s conference room on February 23, 2022. The notice of the meeting was sent to all supervisors by hand, e-mail, fax and other forms on February 21, 2022. The meeting was convened and presided over by Mr. Zheng Degang, chairman of the board of supervisors of the company. Three supervisors should attend the meeting and three supervisors actually attended the meeting. The convening and convening of the meeting shall comply with the relevant provisions of the company law and the articles of association.
2、 Deliberation at the meeting of the board of supervisors
1. The proposal on the change of the board of supervisors of the company and the nomination of candidates for non employee representative supervisors of the third board of supervisors was deliberated and adopted
In accordance with the company law and other laws and regulations and the articles of association, the company conducts the general election of the board of supervisors. The board of supervisors of the company consists of 3 supervisors, including 2 non employee representative supervisors, elected by the general meeting of shareholders; One employee representative supervisor shall be elected by the employee representative of the company through the employee congress.
The second board of supervisors of the company plans to nominate and recommend Mr. Tang Ye and Ms. Xu Juan as candidates for non employee representative supervisors of the third board of supervisors of the company (please refer to the annex for resume). After the above two candidates for non employee representative supervisors are considered and elected at the first extraordinary general meeting of shareholders in 2022, they will form the third board of supervisors of the company together with the employee representative supervisors democratically elected by the employee congress. The term of office of the third board of supervisors is three years from the date of deliberation and approval of the first extraordinary general meeting of shareholders in 2022.
According to relevant regulations, in order to ensure the normal operation of the board of supervisors, before the election of the new board of supervisors, the supervisors of the second board of supervisors of the company will continue to perform their duties in accordance with the provisions of relevant laws and regulations until the election of the new board of supervisors. For details, please refer to www.cn.info.com.cn Announcements on.
The supervisors present at the meeting voted on the above candidates one by one, and the voting results are as follows: 1.1 nominate Mr. Tang Ye as the candidate for non employee representative supervisor of the third board of supervisors of the company. The voting results: 3 votes in favor, 0 votes against and 0 abstention.
1.2 Ms. Xu Juan was nominated as the candidate of non employee representative supervisor of the third session of the board of supervisors of the company. The voting results: 3 in favor, 0 against and 0 abstention.
This proposal needs to be submitted to the company’s first extraordinary general meeting in 2022 for deliberation and election by cumulative voting system.
2. Deliberating the proposal on the proposed purchase of directors, supervisors and senior managers’ liability insurance
The company’s purchase of directors, supervisors and senior managers’ liability insurance is conducive to improving the risk control system, protecting the rights and interests of the company and its directors, supervisors and senior managers, and promoting relevant responsible personnel to fully exercise their supervision rights and perform relevant duties. The deliberation procedures for the purchase of directors, supervisors and senior managers’ liability insurance are legal and compliant, and there is no damage to the interests of the company and all shareholders.
See details published on cninfo.com.cn on the same day Announcement on the proposed purchase of directors, supervisors and senior managers’ liability insurance.
Voting result: all supervisors of the board of supervisors avoided voting. This proposal still needs to be submitted to the first extraordinary general meeting of shareholders of the company in 2022 for deliberation.
It is hereby announced.
Intco Medical Technology Co.Ltd(300677) board of supervisors
February 23, 2022
Attachment: resume of non employee representative supervisor candidates of the third board of supervisors
Tang Ye, male, Chinese nationality, without permanent residency abroad, was born in 1983 with a bachelor’s degree. From July 2007 to April 2010, worked as an employee of Lejin Electronics (Tianjin) Electric Appliance Co., Ltd; He has been the director of Intco Medical Technology Co.Ltd(300677) planning department since April 2010 and the supervisor of the company since April 2015.
As of the disclosure date of this announcement, Mr. Tang Ye does not hold shares of the company and has no relationship with shareholders holding more than 5% of the shares of the company, actual controllers, other directors, supervisors and senior managers of the company; Not punished by the CSRC and other relevant departments or the stock exchange; There are no circumstances stipulated in the company law and the articles of association that they are not allowed to serve as supervisors of the company, there are no circumstances stipulated in article 3.2.3 of the guidelines for self discipline supervision of listed companies on Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on GEM, and there are no circumstances that they are listed as dishonest Executees.
Xu Juan, female, Chinese nationality, without permanent residency abroad, was born in October 1987 with a bachelor’s degree. He joined Intco Medical Technology Co.Ltd(300677) in November 2015 and is now a supervisor and financial manager.
As of the disclosure date of this announcement, Ms. Xu Juan holds 5175 shares of the company, and has no relationship with shareholders holding more than 5% of the shares of the company, actual controllers, other directors, supervisors and senior managers of the company; Not punished by the CSRC and other relevant departments or the stock exchange; There are no circumstances stipulated in the company law and the articles of association that they are not allowed to serve as supervisors of the company, there are no circumstances stipulated in article 3.2.3 of the guidelines for self discipline supervision of listed companies on Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on GEM, and there are no circumstances that they are listed as dishonest Executees.
